摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Camphersaeureanhydrid | 76-32-4

中文名称
——
中文别名
——
英文名称
Camphersaeureanhydrid
英文别名
(5s)-1,8,8-Trimethyl-3-oxabicyclo[3.2.1]octane-2,4-dione
Camphersaeureanhydrid化学式
CAS
76-32-4;595-29-9;595-30-2;595-31-3
化学式
C10H14O3
mdl
——
分子量
182.219
InChiKey
VFZDNKRDYPTSTP-ZMMDDIOLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    223°C (dec.)
  • 沸点:
    270.0±0.0 °C(Predicted)
  • 密度:
    1.137±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S26
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3

SDS

SDS:f69dbb6dc6d334f8eab2703b50a5d769
查看

文献信息

  • Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
    申请人:Alberte Randall S.
    公开号:US20090124690A1
    公开(公告)日:2009-05-14
    The present invention relates to, in part, novel sulfate and bisphenol compounds useful for the recognition, attachment and growth of unwanted biologics on natural and manmade surfaces. Another aspect of the invention relates to combinatorial libraries for producing the same. Another aspect of the invention relates to pharmaceutical formulations comprising the same.
  • [EN] GENERATION OF COMBINATORIAL SYNTHETIC LIBRARIES AND SCREENING FOR NOVEL PROADHESINS AND NONADHESINS<br/>[FR] PRODUCTION DE BANQUES SYNTHÉTIQUES COMBINATOIRES ET CRIBLAGE DE NOUVELLES PROADHÉSINES ET NONADHÉSINES
    申请人:CERNOFINA LLC
    公开号:WO2009076618A2
    公开(公告)日:2009-06-18
    The present invention relates to, in part, novel sulfate and bisphenol compounds useful for the recognition, attachment and growth of unwanted biologies on natural and manmade surfaces. Another aspect of the invention relates to combinatorial libraries for producing the same. Another aspect of the invention relates to pharmaceutical formulations comprising the same.
查看更多